Boston Scientific, Inc. BSX recently received FDA approval for an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (“SCS”) Systems. With this approval, the system will be available ...

MARLBOROUGH, Mass., Sept. 30, 2020 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the European launch of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) Systems. The ...

Marlborough medical device manufacturer Boston Scientific Corp. has announced a limited market release of a new pain-relief system that uses electrical impulses in the spine to block pain signals. The ...

Marlborough medical technology firm Boston Scientific has received approval from the U.S. Food and Drug Administration for its WaveWriter Alpha spinal cord stimulator device to be used to treat low ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an expanded indication of Boston Scientific’s spinal cord stimulation system that treats ...

On his good nights, John, a Colorado retiree, dreamed of playing golf again. On bad ones, simply brushing his feet against cotton sheets triggered sleepless agony. He suffered from acute diabetic ...

In January 1999, Marianne, a nurse in Houston, Texas, was helping coworkers lift a patient when she felt a twinge in her back. At first, she believed the pain she felt was nothing more than a tweaked ...

The FDA approved Boston Scientific's Spectra WaveWriter Spinal Cord Stimulator System. Here's what you should know: 1. The system is the first and only FDA-approved system that simultaneously provides ...

Boston Scientific Corporation BSX recently announced the receipt of the FDA’s approval for its WaveWriter Alpha portfolio of Spinal Cord Stimulator (“SCS”) Systems. The U.S. commercial launch of the ...

System offers multiple non-drug therapies for people with chronic pain PARIS, Jan. 31, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Spectra ...